Biospring Partners, a NYC & Boston-based new venture capital firm that invests in growth stage life sciences technology companies, has made its debut.
The first investment was made in Abzena (read here).
Founded in 2020, by Michelle Dipp, MD PhD and Jennifer Lum, Biospring Partners focuses on companies using technology to drive innovation and efficiency across the life sciences sector.
The firm is positioned to partner with life sciences technology companies that have the potential to fundamentally change how we research, diagnose and treat disease.
FinSMEs
28/07/2020